Affiliation:
1. St. Petersburg State University
Abstract
The article presents data on the features of hypertension (HTN) and the risk factors for its development in patients with psoriasis (PsO) and psoriatic arthritis (PsA). PsO and PsA are often accompanied by cardiovascular diseases which are associated with both chronic systemic Th1-Th17-mediated inflammation and metabolic changes in this group of patients. Currently, data show high rates of HTN in PsO, however, the pathophysiological relationship of these pathologies has not been fully determined. HTN development in PsO and PsA is mediated by many factors. Firstly, metabolism disorders including hyperuricemia, hyperglycemia, dyslipidemia can play a role. Moreover, PsO and PsA often cause stress and depression predisposing to smoking, alcohol consumption, hypodynamia, which are modifiable cardiovascular risk factors. Also, the medications for skin lesions and joint inflammation can lead to high blood pressure. In conclusion, there is no reason to avoid the use of certain antihypertensive drugs in PsO and PsA. Cardiovascular pathology significantly affects the quality of life, social adaptation, and the treatment opportunities of PsO and PsA.
Publisher
Arterialnaya Gipertenziya
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference73 articles.
1. Agafonova EM, Klyukvina NG, Urumova MM. Coexistence of systemic lupus erythematosus and psoriatic arthritis: literature data and case description. Modern rheumatology. 2018;12(4):123–128. doi:10.14412/1996-7012-2018-4-123-128. In Russian.
2. Barilo AA, Smirnova SV, Smolnikova MV. Immunity parameters in patients with psoriatic arthritis depending on age. Medical immunology (Russia). 2019;21(1):69–76. doi:10.15789/1563-0625-2019-1-69-76. In Russian.
3. Torshina IE, Zirchik AA, Gelt TD. Significance of onychodystrophy in predicting cardiovascular diseases in patients with psoriasis. Difficult patient. 2017;15(6–7):28–30. In Russian.
4. Panshina NN, Shilova LN. Clinical features of the metabolic syndrome in patients with psoriatic arthritis. Volgograd Scientific Medical Journal. 2017:31–33. In Russian.
5. Favarato MH, Mease P, Gonçalves CR, Goncalves SC, Sampaio-Barros PD, Goldenstein-Schainberg C. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis. Clin Exp Rheumatol. 2014;32(2):182–187.